Steroid bone loss: scientists hunt for a warning sign
NCT ID NCT06421597
First seen Apr 10, 2026 · Last updated May 16, 2026 · Updated 4 times
Summary
This study aims to find a biological marker that can identify people at risk of bone loss from glucocorticoid (steroid) treatment. 36 healthy volunteers aged 18-50 will be randomly assigned to receive either a glucocorticoid or a placebo. Researchers will take blood, bone marrow, bone tissue, and fat samples, and perform a glucose test to measure changes in bone turnover markers over 15 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS SECONDARY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital of South West Jutland
Esbjerg, 6700, Denmark
-
Odense University Hospital
Odense C, 5000, Denmark
Conditions
Explore the condition pages connected to this study.